G
Geneseeq
Precision oncology solutions maximizing treatment benefits through cutting-edge genomic profiling and AI-powered bioinformatics
About Geneseeq
Geneseeq is a pioneering startup in the field of precision medicine, specifically focusing on cancer care. The company utilizes advanced genomic profiling technology to accelerate the process of precision cancer care. Geneseeq's services are designed to cater to a wide range of clients, including cancer patients, biopharma companies, and research partners.
Read full description
The company operates in the healthcare and biotechnology market, offering a diverse range of cancer genomic testing. Geneseeq's business model revolves around providing comprehensive genomic insights to help match cancer patients with optimal treatments, including targeted therapy and immunotherapy. This is achieved by analyzing over 400 genes through their pan-cancer panel, while specific panels target individual cancer types.
Geneseeq also partners with biopharma and research partners, offering full research services, including project design and management, next-generation sequencing, quality control, and data analysis. The company has been involved in over 2000 research projects, providing high-quality genomic data to accelerate translational research, which is the process of applying findings from basic science to enhance human health and well-being.
The company generates revenue through the services it offers, including genomic testing and research services. Geneseeq prides itself on its high sequencing capacity, having sequenced over 900,000 samples to date, with a turnaround time of just five business days.
At a glance
- Status
- Operational
- Founded
- 2008
- Headquarters
- Toronto, Canada
- Employees
- 32
- Open positions
- None listed
- Dealroom signal
- 37.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, DNA, Genetics and genomics, Genome Engineering, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Geneseeq.
Funding history
Company financing events and reported valuations.
Growth signals
Latest recorded traffic for Geneseeq is 30K monthly website visits, up 597.7% over the last three months. Geneseeq's team grew 0% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 AntegenesGenetic tests for personalized cancer risk prevention |
Tartu, Estonia | Operational | 11 | $3.4M | $7M |
 FemtogenixDNA-interactive payloads for antibody-drug conjugates |
St Albans, United Kingdom | Operational | |||
 Mediphage BioceuticalsCures for chronic diseases |
Toronto, Canada | Operational | |||
 EdiGeneDedicated to the development of genome editing technology for human health |
Changping District, China | Operational | |||
 AnchorDxAnchorDx is a precision medicine firm |
Guangzhou, China | Operational | |||
 GeneAdviserOur mission is to make genetic testing for rare diseases more accessible to clinicians around the world |
Cambridge, United Kingdom | Operational | |||
 Atossa GeneticsHealthcare company developing cellular and molecular diagnostic risk assessment products for breast cancer patients |
Seattle, United States | Operational | |||
 Shield BioFighting antibiotic resistance with genomics |
Santa Clara, United States | Closed |
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
DNV capital
Series B and later5 investors entered at this stage
- CMChina Reform Fund Management
E Fund Management
SB China Capital
Lilly Asia Ventures
Xiamen C&D
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Geneseeq on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Geneseeq’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.